Overview

Study to Investigate the Pharmacokinetic Comparability of Dosing Triferic AVNU IV by Continuous Infusion and IV Bolus.

Status:
Completed
Trial end date:
2021-04-02
Target enrollment:
Participant gender:
Summary
This study will investigate the administration of Triferic AVNU intravenously by three different administration schedules compared to continuous infusion over 3 hours
Phase:
Phase 1/Phase 2
Details
Lead Sponsor:
Rockwell Medical Technologies, Inc.